CLDI.WS

Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00

Delisted

CLDI.WS was delisted on the 17th of October, 2024.

1 hedge funds and large institutions have $1.01K invested in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.

Holders
1
Holders Change
-14
Holders Change %
-93.33%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
EAM
1
Exos Asset Management
New York
$1.01K
PAMP
2
Polar Asset Management Partners
Ontario, Canada
-$30.2K -2,165,086 Closed
DCM
3
Driehaus Capital Management
Illinois
-$9.3K -750,000 Closed
FC
4
Finepoint Capital
Massachusetts
-$8.58K -655,200 Closed
6CM
5
683 Capital Management
New York
-$7.86K -599,702 Closed
AC
6
Aristeia Capital
Connecticut
-$6.9K -494,400 Closed
Nomura Holdings
7
Nomura Holdings
Japan
-$6.08K -467,818 Closed
SCM
8
Shaolin Capital Management
Florida
-$4.33K -330,547 Closed
CAC
9
Cowen and Company
New York
-$2.25K -171,536 Closed
Citadel Advisors
10
Citadel Advisors
Florida
-$926 -70,701 Closed
Walleye Capital
11
Walleye Capital
New York
-$478 -36,469 Closed
Walleye Trading
12
Walleye Trading
New York
-$263 -20,052 Closed
CS
13
Clear Street
New York
-$87 -6,617 Closed
UBS Group
14
UBS Group
Switzerland
-$70 -5,398 Closed
HCM
15
Highbridge Capital Management
New York
-$20.7K